HomeQuestion

For a patient with metastatic NSCLC who had progression x2 at a single site treated w RT, would you switch systemic treatment?

1

1 Answers

Mednet Member

Medical Oncology · Florida Cancer Specialists & Research Institute

Continue immunotherapy.

Register or Sign In to see full answer